ArticleJournal for immunotherapy of cancer2020

Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses.

Katherine J Brempelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.